| 000 | 01758 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514050931.0 | ||
| 264 | 0 | _c20030210 | |
| 008 | 200302s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.M203793200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhou, Yunli | |
| 245 | 0 | 0 |
_aDNA damage-induced inhibition of securin expression is mediated by p53. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cJan 2003 |
||
| 300 |
_a462-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aBleomycin _xpharmacology |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 |
_aNocodazole _xpharmacology |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 | _aSecurin |
| 650 | 0 | 4 |
_aTrans-Activators _xgenetics |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aMehta, Kshama R | |
| 700 | 1 | _aChoi, Andrew P | |
| 700 | 1 | _aScolavino, Staci | |
| 700 | 1 | _aZhang, Xun | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 278 _gno. 1 _gp. 462-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M203793200 _zAvailable from publisher's website |
| 999 |
_c12212192 _d12212192 |
||